��������

Dr. Sathiyaseelan (“Sathi”) was Director of Bioanalytical Development at SmartCells, Inc. at the time of its sale to Merck & Co. in 2010. Before that, he was Senior Manager, Vaccine Preclinical Development Projects at Vaxine Pty Ltd, Adelaide, Australia and Director (Immunology R&D and Therapeutic Antibody Development) at Hematech Inc., Sioux Falls, SD. Sathi earned his Ph.D. in Immunology from the University of Massachusetts, Amherst and his Bachelor of Veterinary Medicine & Surgery degree from the University of Peradeniya, Sri Lanka.